|
End-of-day quote
Taiwan S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 10.60 TWD | -2.30% |
|
-5.78% | -21.48% |
| 08-04 | PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-03 | PhytoHealth's Revenue Rises 18% in May | MT |
Company Valuation: PhytoHealth Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,140 | 4,628 | 3,794 | 4,310 | 3,337 | 2,681 |
| Change | - | 11.8% | -18.03% | 13.61% | -22.58% | -19.64% |
| Enterprise Value (EV) 1 | 3,397 | 3,244 | 2,463 | 3,072 | 2,275 | 1,632 |
| Change | - | -4.49% | -24.08% | 24.73% | -25.94% | -28.25% |
| P/E | -46.9x | -58.7x | -47.8x | -91.5x | -45.4x | -46.1x |
| PBR | 3.22x | 2.34x | 1.99x | 2.24x | 1.75x | 1.43x |
| PEG | - | 2.2x | -69.86x | 2.2x | -0.8x | 2.2x |
| Capitalization / Revenue | 45.1x | 27.4x | 28x | 26.5x | 21.7x | 19.9x |
| EV / Revenue | 37x | 19.2x | 18.2x | 18.9x | 14.8x | 12.1x |
| EV / EBITDA | -26.8x | -36x | -21.4x | -38.8x | -19.2x | -11.9x |
| EV / EBIT | -19.9x | -24.6x | -15.7x | -25.2x | -14.2x | -9.35x |
| EV / FCF | -33.1x | -50.5x | -55.5x | -52.5x | -56.2x | -37.7x |
| FCF Yield | -3.02% | -1.98% | -1.8% | -1.9% | -1.78% | -2.65% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.5393 | -0.3971 | -0.3998 | -0.2372 | -0.3701 | -0.293 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 91.81 | 168.9 | 135.5 | 162.5 | 153.6 | 134.6 |
| EBITDA 1 | -126.5 | -90.16 | -114.8 | -79.16 | -118.3 | -136.7 |
| EBIT 1 | -170.4 | -132.1 | -156.7 | -121.7 | -160.2 | -174.6 |
| Net income 1 | -88.24 | -77.72 | -79.41 | -47.12 | -73.5 | -58.2 |
| Net Debt 1 | -743 | -1,384 | -1,331 | -1,238 | -1,062 | -1,049 |
| Reference price 2 | 25.30 | 23.30 | 19.10 | 21.70 | 16.80 | 13.50 |
| Nbr of stocks (in thousands) | 163,619 | 198,619 | 198,619 | 198,619 | 198,619 | 198,619 |
| Announcement Date | 2/25/21 A | 2/23/22 A | 3/1/23 A | 2/27/24 A | 2/27/25 A | 3/2/26 A |
1TWD in Million2TWD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 64.22M | ||
| 39.62x | 13.42x | 28.51x | 0.5% | 1,206B | ||
| 40.43x | 6.79x | 19.09x | 1.93% | 665B | ||
| 37.52x | 8.51x | 17.57x | 2.38% | 515B | ||
| 20.98x | 5.12x | 12.74x | 2.57% | 381B | ||
| 97.18x | 5.94x | 25.33x | 2.32% | 362B | ||
| 23.18x | 5.95x | 14.36x | 2.69% | 307B | ||
| 24.46x | 4.89x | 13.77x | 1.79% | 289B | ||
| 23.75x | 7.3x | 13.55x | 2.19% | 249B | ||
| -39.18x | 7.28x | 45.82x | 1.98% | 207B | ||
| Average | 29.77x | 7.24x | 21.19x | 2.04% | 417.98B | |
| Weighted average by Cap. | 35.67x | 8.55x | 21.86x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4108 Stock
- Valuation PhytoHealth Corporation
Select your edition
All financial news and data tailored to specific country editions
















